Granules India Limited has announced the incorporation of its wholly owned foreign subsidiary in Mexico, named TRITON FARMACEUTICA S.A. de C.V. This strategic move aims to establish the company’s presence in the Mexican market for the manufacturing, promotion, sale, and distribution of pharmaceuticals and related products. The new entity was incorporated on October 22, 2026, and is positioned to drive international growth for Granules India.
Granules India Expands International Footprint
Granules India Limited has officially incorporated a new wholly owned foreign subsidiary in Mexico. The entity, named TRITON FARMACEUTICA S.A. de C.V., marks a significant step in the company’s global expansion strategy. This incorporation was completed on October 22, 2026, as per the company’s disclosure.
Strategic Objectives in Mexico
The primary objective for establishing TRITON FARMACEUTICA S.A. de C.V. is to facilitate the manufacturing, promotion, sale, and distribution of pharmaceuticals and other related products within the Mexican market. This initiative is expected to open new avenues for revenue generation and strengthen Granules India’s presence in Latin America. The subsidiary is part of the company’s ongoing efforts to diversify its operational base and tap into emerging markets.
Subsidiary Details
The newly incorporated entity has an authorized share capital of 4,50,000 Shares of MXN 10.00 each. While the subsidiary has been incorporated, it has not yet commenced its business operations. Granules India holds 100% ownership of the subsidiary. The Promoter and Promoter Group of Granules India Limited do not hold any interest in this newly incorporated entity, ensuring an arms-length transaction structure.
Source: BSE
